Диссертация (1173216), страница 16
Текст из файла (страница 16)
- Vol. 103, №12. - P. 4561-4568. doi:10.1210/jc.2018-01227.96.Grimes, D.A. Oral contraceptives for functional ovarian cysts. / D.A.Grimes, L.B. Jones, L.M. Lopez, K.F. Schulz // Cochrane Database Syst Rev. –2014. - Vol., №4. - P.CD006134. doi: 10.1002/14651858.CD006134.pub5.97.Gupta, P. Analysis of Cohesin Function in Gene Regulation andChromatin Organization in Interphase. / P. Gupta, T.
Lavagnolli, H. MiraBontenbal, M. Merkenschlager // Methods Mol Biol. - 2017. - Vol.1515:197-216.98.Herington, J.L. Immune interactions in endometriosis. / J.L.Herington, K.L. Bruner-Tran, J.A. Lucas, K.G. Osteen // Expert Rev ClinImmunol. - 2011. - Vol. 7, №5. - P. 611–626. doi: 10.1586/eci.11.53-4399.Howard, F.M. Endometriosis and mechanisms of pelvic pain.
/ F.M.Howard //J Minim Invasive Gynecol. - 2009. - Vol. 16, №5. - P. 540-50. doi:10.1016/j.jmig.2009.06.017.110100. Hsiao, K.Y. Epigenetic regulation of the pathological process inendometriosis. / K.Y. Hsiao, M.H. Wu, S.J. Tsai // Reprod Med Biol. - 2017. - Vol.16, №4.
- P. 314-319. doi: 10.1002/rmb2.12047.101. Immunology of endometriosis. / L.D.G.C. Riccio, P. Santulli, L.Marcellin, M.S Abrão [et al.] // Best Pract Res Clin Obstet Gynaecol. - 2018. pii:S1521-6934, №18)30028-2. doi: 10.1016/j.bpobgyn.2018.01.010.102. Impact of endometriosis on quality of life and mental health: pelvicpain makes the difference.
/ F. Facchin, G. Barbara, E. Saita, P. Mosconi [et al.] // JPsychosomObstetGynaecol.2015;36(4):135-41.doi:10.3109/0167482X.2015.1074173.103. Increased levels of human neutrophil peptides 1, 2, and 3 in peritonealfluid of patients with endometriosis: association with neutrophils, T cells and IL-8./L. Milewski, P.
Dziunycz, E. Barcz, D. Radomski [et al.] // J Reprod Immunol. 2011. - Vol. 91, №1-2. - P. 64-70. doi: 10.1016/j.jri.2011.05.008.104. Intraperitoneal immune cell status in infertile women with and withoutendometriosis. / N. Tariverdian, F. Siedentopf, M. Rücke, S.M. Blois [et al.] // JReprodImmunol.-2009.-Vol.80,№1-2.-P.80-90.doi:10.1016/j.jri.2008.12.005.105. Ioannou, D. Chromosome territory repositioning induced by PHAactivation of lymphocytes: A 2D and 3D appraisal. / D.
Ioannou, L. Kandukuri,J.L. Simpson, H.G. Tempest // Mol Cytogenet. – 2015. -. Vol.8. – P.47. doi:10.1186/s13039-015-0146-3. eCollection 2015.106. Jee, B.C. Impact of GnRH agonist treatment on recurrence ofovarianen dometriosis after conservative laparoscopic surgery / B.C. Jee, J.Y. Lee,C.S. Suh [et al.] // Fertil.
Steril. - 2009. - Vol. 91. № 1. P. 40–44.107. Jeng, C.J. A comparison of progestogens or oral contraceptives andgonadotropin-releasing hormone agonists for the treatment of endometriosis: asystematic review. / C.J. Jeng, L. Chuang, J.Shen // Expert Opin Pharmacother. 2014. – Vol.15, №6. - P. 767-73. doi: 10.1517/14656566.2014.888414.111108. Jeung, I.
Decreased Cytotoxicity of Peripheral and Peritoneal NaturalKiller Cell in Endometriosis. / I. Jeung, K. Cheon, M.R. Kim // Biomed Res Int. 2016. - Vol. 2016. - P.2916070. doi: 10.1155/2016/2916070.109. Kavoussi, S.K. New paradigms in the diagnosis and management ofendometriosis. / S.K. Kavoussi , C.S. Lim, B.D.
Skinner [et al.] // Curr Opin ObstetGynecol.-2016.-Vol.28,№4.-P.267-76.doi:10.1097/GCO.0000000000000288.110.Komorowska, В. Autoimmune premature ovarian failure. / В.Komorowska // Prz Menopauzalny. - 2016. - Vol. 15, №4. - P. 210–214. doi:10.5114/pm.2016.65666111. Management of ovarian endometriomas. / C. Chapron, P. Vercellini,H.
Barakat, M. Vieira [et al.] // Hum Reprod Update. – 2002. – Vol.8, №6. – P.591-597.112. Management of the pain associated with endometriosis: an update ofthe painful problems. / Y. Ozawa, T. Murakami, Y. Terada, N. Yaegashi [et al.] //J Exp Med. - 2006. - Vol.
210, №3. - P. 175-188113. McCormack, P.L. Dienogest: a review of its use in the treatment ofendometriosis. / P.L. McCormack // Drugs. - 2010. - Vol. 70, №16. - P. 2073-2088.doi: 10.2165/11206320-000000000-00000.114. Mechsner, S. Endometriosis: An often unrecognized pain disorder. / S.Mechsner // Schmerz. 2016. Vol. 30, №5. - P. 477-490. DOI:10.1007/s00482-0160154-1-18.115. Molecularmechanismsunderlyingendometriosispathogenesisrevealed by bioinformatics analysis of microarray data.
/ S. Ping, C. Ma, P. Liu, L.Yang [et al.] // Arch Gynecol Obstet. - 2016 - Vol.293, №4. - P.797-804DOI: 10.1007/s00404-015-3875-y.116. Morotti, M. Mechanisms of pain in endometriosis. / M. Morotti, K.Vincent, C.M. Becker // Eur J Obstet Gynecol Reprod Biol.
2017. Vol. 209: 8-13.doi: 10.1016/j.ejogrb.2016.07.497.112117. Mueck, O.A. Dienogest: an oral progestogen for the treatment ofendometriosis. / O.A. Mueck // Expert. Rev. Obstet. Gynecol. - 2011. - Vol. 6, №1.- P. 5-15 DOI:10.1586/eog.10.71.118. Natural Killer T cell subsets in eutopic and ectopic endometrium: afresh look to a busy corner. / A.S Laganà., O. Triolo, F.M.
Salmeri, R. Granese [etal.] // Arch Gynecol Obstet. - 2016. - Vol. 293, №5. - P. 941-9. doi:10.1007/s00404-015-4004-7.119. Nickkho-Amiry, M. The effect of surgical management ofendometrioma on the IVF/ICSI outcomes when compared with no treatment? Asystematic review and meta-analysis. / M.
Nickkho-Amiry, R. Savant, K.Majumder, E. Edi-O'sagie [et al.] // Arch Gynecol Obstet. - 2018. - Vol. 297, №4. P.1043-1057. doi: 10.1007/s00404-017-4640-1.120. Nirgianakis,K.Dienogestmediatesmidkine suppressioninendometriosis. / K. Nirgianakis, G. Grandi, B. McKinnon, N. Bersinger [et al.] //HumanReproduction.-2016.-Vol.31,№9.-P.1981-1986.DOI: 10.1093/humrep/dew180121. Nisenblat, V. Imaging modalities for the non-invasive diagnosis ofendometriosis. / V. Nisenblat, P.M.
Bossuyt, C. Farquhar, N. Johnson [et al.] //Cochrane Database Syst Rev. - 2016. - Vol. 2. - CD009591.122. NK cell abnormality and its treatment in women with reproductivefailures such as recurrent pregnancy loss, implantation failures, preeclampsia, andpelvic endometriosis. / A. Fukui, M. Kamoi, A. Funamizu, K. Fuchinoue [et al.] //Reprod Med Biol. - 2015. - Vol.
14, №4. - P.151-157. doi: 10.1007/s12522-0150207-7.123. Osuga, Y. Novel therapeutic strategies for endometriosis: apathophysiological perspective. / Y. Osuga // Gynecol. Obstet. Invest. 2008. Vol.66. Suppl. 1. P. 3–9.124. Pääkkö,E.Diagnostics of endometriosis byusingmagneticresonance imaging./ E. Pääkkö, M. Niinimäki // Duodecim. - 2017. - Vol. 133, №1.- P.61-67.113125. Parasar, P.
Endometriosis: Epidemiology, Diagnosis and ClinicalManagement. / P. Parasar, P. Ozcan, K.L. Terry // Curr Obstet Gynecol Rep. 2017. - Vol. 6, №1. - P. 34-41. doi: 10.1007/s13669-017-0187-1.126. Pathophysiology and Immune Dysfunction in Endometriosis. / S.H.Ahn, S.P. Monsanto, C. Miller, S.S. Singh [et al.] // Biomed Res Int. – 2015. –2015. – P.795976. doi: 10.1155/2015/795976.127.
Plant-derivedmedicinesfortreatmentofendometriosis:Acomprehensive review of molecular mechanisms. / F. Bina, S. Soleymani, T.Toliat, M. Hajimahmoodi [et al.] // Pharmacol Res. – 2018. – Vol.139. – P. 76-90.doi: 10.1016/j.phrs.2018.11.008.128. Prevention of the complications related to hysteroscopy: guidelines forclinical practice.
/ X. Deffieux, T. Gauthier, N. Ménager, G. Legendre [et al.] // JGynecol Obstet Biol Reprod. – 2013. – Vol.42, №8. – P.1032-1049.129. Quality of Life in Women with Endometriosis: An IntegrativeReview./ M.C.P. Marinho, T.F. Magalhaes, L.F.C. Fernandes, K.L. Augusto [etal.] // J Womens Health. – 2018. – Vol.27, №3. – P.399-408. doi:10.1089/jwh.2017.6397130. Rawlings, J.S. Roles of SMC Complexes During T LymphocyteDevelopment and Function. / J.S. Rawlings // Adv Protein Chem Struct Biol. 2017. - Vol.
106. – P.17-42. doi: 10.1016/bs.apcsb.2016.08.001. Epub 2016 Sep22. Review.131. Redwine, D.B. Laparoscopic treatment of complete obliteration of thecul-de-sac associated with endometriosis: long-term follow-up of en bloc resection/ D.B. Redwine, J.T. Wright // Fertil. Steril. - 2001. - Vol.76. - P. 358–365.132. The Apoptotic, Angiogenic and Cell Proliferation Genes CD63,S100A6 e GNB2L1 are Altered in Patients with Endometriosis. / V.A. Gomes,C.M. Bonocher, J.C. Rosa-E-Silva, C.C.P. de Paz [et al.] // Rev Bras GinecolObstet.
- 2018. - Vol. 40, №10. - P. 606-613. doi: 10.1055/s-0038-1673364.133. Ultrasound mapping of pelvic endometriosis: does the location andnumber of lesions affect the diagnostic accuracy? A multicenter diagnostic114accuracy study. / T.K. Holland, A. Cutner, E. Saridogan, D. Mavrelos [et al.] //BMC Womens Health. - 2013. - Vol.
13: 43. doi: 10.1186/1472-6874-13-43.134. What do we know about regulatory T cells and endometriosis? Asystematic review. / I.B.L. de Barros, H. Malvezzi, B.Y. Gueuvoghlanian-Silva,C.A. Piccinato [et al.] // J Reprod Immunol. – 2017. – Vol.120. – P.48-55. doi:10.1016/j.jri.2017.04.003. -56135. Strategies and surgical management of endometriosis: CNGOF-HASEndometriosis Guidelines. / H. Roman, M. Ballester, J.
Loriau, M. Canis [et al.] //Gynecol Obstet Fertil Senol. - 2018. - Vol. 46, №3. - P.326-330.doi:10.1016/j.gofs.2018.02.020.136. Sallam, H.N.. Longterm pituitary down-regulation before in vitrofertilization ,IVF) for women with endometriosis/ H.N. Sallam, J.A. GarciaVelasco, S. Dias, A. Arici [et al.] // Cochrane Database Syst. Rev. 2006. Vol. 1.CD004635.137. Seyhan, A.
The Impact of Endometriosis and Its Treatment onOvarian Reserve. / A. Seyhan, B. Ata, G. Uncu // Semin Reprod Med. - 2015. Vol. 33, №6. - P. 422-8. doi: 10.1055/s-0035-1567820.138. Shah, R. Review of Endometriosis Diagnosis through Advances inBiomedical Engineering. / R. Shah, R.P. Jagani // Crit Rev Biomed Eng.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
